Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
The Fanconi anemia complementation group (FANC) currently includes FANCA, FANCB, FANCC, FANCD1 (also called BRCA2), FANCD2, FANCE, FANCF, FANCG, FANCI, FANCJ (also called BRIP1), FANCL, FANCM and FANCN (also called PALB2). Additionally we are shipping FANCD2 Kits (12) and and many more products for this protein.
Showing 10 out of 164 products:
Dog (Canine) Polyclonal FANCD2 Primary Antibody for FACS, ICC - ABIN151329
Bekker-Jensen, Lukas, Kitagawa, Melander, Kastan, Bartek, Lukas: Spatial organization of the mammalian genome surveillance machinery in response to DNA strand breaks. in The Journal of cell biology 2006
Show all 131 Pubmed References
Dog (Canine) Polyclonal FANCD2 Primary Antibody for ICC, IF - ABIN250520
Garcia-Higuera, Taniguchi, Ganesan, Meyn, Timmers, Hejna, Grompe, DAndrea: Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway. in Molecular cell 2001
Show all 15 Pubmed References
Dog (Canine) Polyclonal FANCD2 Primary Antibody for IHC, IHC (p) - ABIN250521
Rothfuss, Grompe: Repair kinetics of genomic interstrand DNA cross-links: evidence for DNA double-strand break-dependent activation of the Fanconi anemia/BRCA pathway. in Molecular and cellular biology 2003
Show all 15 Pubmed References
Human Monoclonal FANCD2 Primary Antibody for ChIP, IP - ABIN151782
Nomura, Adachi, Koyama: Human Mus81 and FANCB independently contribute to repair of DNA damage during replication. in Genes to cells : devoted to molecular & cellular mechanisms 2007
Show all 10 Pubmed References
Human Polyclonal FANCD2 Primary Antibody for IHC - ABIN966127
Kweekel, Antonini, Nortier, Punt, Gelderblom, Guchelaar: Explorative study to identify novel candidate genes related to oxaliplatin efficacy and toxicity using a DNA repair array. in British journal of cancer 2009
Show all 6 Pubmed References
Human Polyclonal FANCD2 Primary Antibody for WB - ABIN151945
Taniguchi, Garcia-Higuera, Xu, Andreassen, Gregory, Kim, Lane, Kastan, DAndrea: Convergence of the fanconi anemia and ataxia telangiectasia signaling pathways. in Cell 2002
Show all 2 Pubmed References
FANCD2 acts independently of previous S phases to promote alignment and segregation of acentric DNA produced by double-strand breaks.
Fancd2 has a role in DNA repair.
study showed that FANCI (show FANCI Antibodies)-FANCD2 is required for replication-coupled DNA interstrand cross-link (ICL) repair in S phase; results show that multiple steps of the essential S-phase ICL repair mechanism fail when the Fanconi anemia (show PALB2 Antibodies) pathway is compromised
The Fanconi anemia protein (show FANCF Antibodies) FANCM (show FANCM Antibodies) is controlled by FANCD2 and the ATR (show ATR Antibodies)/ATM (show ATM Antibodies) pathways.
silkworm cells deficient for FA proteins FancD2 and FancM (show FANCM Antibodies) exhibit normal sensitivities to hydroxyurea (HU) and camptothecin (CPT (show DHDDS Antibodies))
It was shown that silkworm FancD2 is monoubiquitinated depending on FancI (show FANCI Antibodies) and FancL (show FANCL Antibodies), and stabilized on chromatin, following mitomycin C. Depletion of FancD2, FancI (show FANCI Antibodies) or FancL (show FANCL Antibodies) effected cell proliferation in the presence of mitomycin C.
demonstrate that the FANC pathway acts downstream MiTF (show MITF Antibodies) and establish the existence of an epistatic relationship between MiTF (show MITF Antibodies) and the FANC pathway
we discuss the recent and relevant studies to provide an updated review on the roles of FANCD2 in the DNA damage response.
FANCI (show FANCI Antibodies) phosphorylation activates the FANCI (show FANCI Antibodies)/D2 complex.
FANCD2 and PALB2 (show PALB2 Antibodies), as indicators of the upstream and downstream arms, respectively, colocalize independently of each other in response to DNA damage.
FANCD2 has a ubiquitination-independent role in countering endogenous levels of replication stress, a function that is critical for the maintenance of genomic stability.
Data suggest that FANCI (show FANCI Antibodies) and FANCD2 have partially non-overlapping and possibly even opposing roles during the replication stress response.
Fanconi anemia (show PALB2 Antibodies) FANCD2 and FANCI (show FANCI Antibodies) proteins regulate the nuclear dynamics of splicing factors, such as SF3B1 (show SF3B2 Antibodies).
People with Fanconi anemia (show PALB2 Antibodies), or healthy people who develop sporadic mutations in FANCD2, may be hypersensitive to the carcinogenic activity of coffee.
Results indicate the importance of DNA binding and nuclear localization sequences (NLS (show ALDH1A2 Antibodies)) residues in Fanconi Anemia Group D2 Protein (FANCD2) to activate an efficient Fanconi anemia (show PALB2 Antibodies) (FA) pathway.
FANCB (show BRCA2 Antibodies) dimer coordinates FANCD2:FANCI (show FANCI Antibodies) monoubiquitination by two FANCL (show FANCL Antibodies) RING-ligases. Deubiquitination of FANCD2:FANCI (show FANCI Antibodies) by USP1 (show USP1 Antibodies):UAF1 (show WDR48 Antibodies) occurs only when DNA is removed.
Data show that stromal cell lines derived from both K14E7 Fancd2-/- and Fancd2-/- cultures were radiosensitive.
Fancd2-/- mice exhibit a pervasive developmental HSPC defect that echoes the constitutional defects evident at birth in a subset of FA patients.
loss of Fancd2 yields significant defects to fetal liver hematopoiesis, particularly the HSC (show FUT1 Antibodies) population, which mimics key phenotypes from adult Fancd2 KO bone marrow independently of aging-accrued DNA damage.
Data that suggest Usp1 (ubiquitin specific peptidase 1 (show USP1 Antibodies)) down-regulation by autocleavage is critical for Usp1 (show USP1 Antibodies) to exert role in DNA interstrand crosslink repair; Usp1 (show USP1 Antibodies) role is de-ubiquitination of Fancd2 and Pcna (proliferating cell nuclear antigen (show PCNA Antibodies)).
recruitment of Fan1 (show FAN1 Antibodies) by ubiquitinated-Fancd2 is dispensable for DNA interstrand cross-links repair
Results show that FANCD2 and ADH5 (show ADH5 Antibodies) protect hematopoietic stem cells, hepatocytes, and nephrons from endogenous DNA damage resulting from accumulation of endogenous formaldehyde.
Combined deficiency of Foxo3a (show FOXO3 Antibodies) and Fancc (show FANCC Antibodies) or Fancd2 not only impairs the self-renewal capacity but also markedly increases the apoptosis of neural stem and progenitor cells (NSPCs), leading to defective neurogenesis.
Data demonstrated that Fancd2 was required for nuclear retention of CA-FOXO3a (show FOXO3 Antibodies) and for maintaining hematopoietic repopulation of the HSCs.
CD25 (show IL2RA Antibodies)(+)Foxp3 (show FOXP3 Antibodies)(+) Tregs of Fanca (show FANCA Antibodies)(-/-) or Fancd2(-/-) mice were less efficient in suppressing the production of GVHD-associated inflammatory cytokines.
Fancd2-Ub activates the transcription of the tumor suppressor TAp63, thereby promoting cellular senescence and blocking skin tumorigenesis.
The Fanconi anemia complementation group (FANC) currently includes FANCA, FANCB, FANCC, FANCD1 (also called BRCA2), FANCD2, FANCE, FANCF, FANCG, FANCI, FANCJ (also called BRIP1), FANCL, FANCM and FANCN (also called PALB2). The previously defined group FANCH is the same as FANCA. Fanconi anemia is a genetically heterogeneous recessive disorder characterized by cytogenetic instability, hypersensitivity to DNA crosslinking agents, increased chromosomal breakage, and defective DNA repair. The members of the Fanconi anemia complementation group do not share sequence similarity\; they are related by their assembly into a common nuclear protein complex. This gene encodes the protein for complementation group D2. This protein is monoubiquinated in response to DNA damage, resulting in its localization to nuclear foci with other proteins (BRCA1 AND BRCA2) involved in homology-directed DNA repair. Alternative splicing results in two transcript variants encoding different isoforms.
Fanconi anemia, complementation group D2
, Fanconi anemia group D2 protein-like
, fanconi anemia protein FANCD2
, Fanconi anemia complementation group D2
, Fanconi anemia group D2 protein
, Fanconi anemia group D2 protein homolog
, Fanconi anemia D2 protein